Molecular Partners AG at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Right. So good morning and good afternoon, everyone. I am James Quigley, European pharma and biotech analyst at Morgan Stanley. It's my pleasure to welcome you all to this session with Molecular Partners. Today, we're joined by the CEO, Patrick Amstutz; the CFO, Andreas Emmenegger; and also Seth Lewis from Investor Relations.
Just before handing over to Patrick, I will remind you that if you wish to ask a question, you can do so by entering it in the text box on the portal. Or you can email me at [email protected], and I'll ask your question for you.
In terms of disclosures. So for important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales rep.
With that explained, over to you, Patrick, to set the scene with a few introductory comments.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
